Pulmonary embolism causes: Difference between revisions
Ochuko Ajari (talk | contribs) |
mNo edit summary |
||
(40 intermediate revisions by 10 users not shown) | |||
Line 6: | Line 6: | ||
|} | |} | ||
{{Pulmonary embolism}} | {{Pulmonary embolism}} | ||
{{ | {{CMG}} {{ATI}}; {{AE}} {{Ochuko}} | ||
==Overview== | ==Overview== | ||
Line 26: | Line 26: | ||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Antithrombin III deficiency]], [[deep vein thrombosis]], [[dyslipidemia]], [[embolism]], [[fat]], [[heart failure]], [[hypercholesterolemia]], [[hypertension]], [[May-Thurner syndrome]], [[Meadows syndrome]], [[Paget-Schroetter disease]], [[venous thrombosis|pelvic vein thrombosis]], [[plasminogen|plasminogen deficiency]], [[thromboembolism]], [[thrombosis]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 40: | Line 39: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Behcet's disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Asparaginase Erwinia chrysanthemi]],[[axitinib]], [[bevacizumab]], [[clomifene]], [[crizotinib]], [[desogestrel and ethinyl estradiol]], [[epirubicin ]], [[Estropipate]], [[Ethacrynic Acid]], [[ethynodiol diacetate and ethinyl estradiol]], [[etonogestrel]], [[fibrinogen]],[[glucocorticoids]], [[goserelin]], [[hormone replacement therapy]], [[idursulfase]], [[interferon gamma]], [[lenalidomide]], [[letrozole]], [[medroxyprogesterone]], [[meropenem]], [[oral contraceptives]], [[ospemifene]], [[palbociclib]], [[pergolide]], [[polidocanol]], [[pramipexole]], [[progesterone]], [[romidepsin]], [[tamoxifen]], [[testosterone]], [[thalidomide]], [[toremifene]], [[trametinib]], [[transdermal contraceptive]], [[vorinostat]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 52: | Line 51: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Polycystic ovary syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 60: | Line 59: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Colorectal cancer]], [[inflammatory bowel disease]], [[liver disease]], [[Paget-Schroetter disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Paroxysmal nocturnal hemoglobinuria]], [[protein C deficiency]], [[protein S deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[antithrombin III deficiency]], [[deep vein thrombosis]], [[embolism]], [[essential thrombocythemia]], [[essential thrombocytosis]], [[factor V Leiden mutation]], [[factor XII|factor XII deficiency]], [[familial dysfibrinogenemia]], [[heparin cofactor II|heparin cofactor II deficiency]], [[heparin-induced thrombocytopenia]], [[hyperviscosity]], [[paroxysmal nocturnal hemoglobinuria]], [[venous thrombosis|pelvic vein thrombosis]], [[plasminogen|plasminogen deficiency]], [[polycythemia vera]], [[protein C deficiency]], [[protein S deficiency]], [[thromboembolism]], [[thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer surgery]], [[neurosurgery]], [[orthopedic surgery]], [[central venous catheter|presence of central venous catheter]], [[vascular surgery]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Infection]], [[tuberculosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Bone fractures]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Corticobasal degeneration]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Dyslipidemia]], [[hypercholesterolemia]], [[hyperhomocysteinemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amniotic fluid]], [[antiphospholipid syndrome]], [[hormone replacement therapy]], [[Meadows syndrome]], [[oral contraceptives]], [[ovarian hyperstimulation syndrome]], [[polycystic ovary syndrome]], [[pregnancy]], [[transdermal contraceptive]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer]], [[colorectal cancer]], [[lung cancer]], [[malignancy]], [[pancreatic cancer]], [[polycythemia vera]], [[prostate cancer]], [[renal cell carcinoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 104: | Line 103: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[heparin-induced thrombocytopenia]], [[neuroleptic malignant syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Psychiatric''' | | '''Psychiatric''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Corticobasal degeneration]], [[neuroleptic malignant syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Pulmonary''' | | '''Pulmonary''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Asthma]], [[lung cancer]], [[thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Chronic renal disease]], [[nephrotic syndrome]], [[renal cell carcinoma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[Behcet's disease]], [[Hughes-Stovin syndrome]], [[prothrombin gene mutation G20210A]], [[rheumatoid arthritis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 128: | Line 127: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Injury]], [[intravenous drug use]], [[surgery]], [[trauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Prostate cancer]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer surgery]], [[immobility|immobilization]], [[neurosurgery]], [[orthopedic surgery]], [[renal transplantation]], [[vascular surgery]] | ||
|- | |- | ||
|} | |} | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{col-begin|width=80%}} | |||
{{col-break|width=33%}} | |||
*[[Amniotic fluid]] | *[[Amniotic fluid]] | ||
*[[Antiphospholipid syndrome]] | *[[Antiphospholipid syndrome]] | ||
Line 156: | Line 155: | ||
*[[Corticobasal degeneration]] | *[[Corticobasal degeneration]] | ||
*[[Deep vein thrombosis]] | *[[Deep vein thrombosis]] | ||
*[[Desogestrel and Ethinyl Estradiol]] | |||
*[[Dyslipidemia]] | *[[Dyslipidemia]] | ||
*[[Ethynodiol diacetate and ethinyl estradiol]] | |||
*[[Embolism]] | *[[Embolism]] | ||
*[[Essential thrombocythemia]] | *[[Essential thrombocythemia]] | ||
*[[Essential thrombocytosis]] | *[[Essential thrombocytosis]] | ||
*[[Etonogestrel]] | |||
*[[Factor V Leiden mutation]] | *[[Factor V Leiden mutation]] | ||
*[[factor XII|Factor XII deficiency]] | *[[factor XII|Factor XII deficiency]] | ||
Line 168: | Line 170: | ||
*[[heparin cofactor II|Heparin cofactor II deficiency]] | *[[heparin cofactor II|Heparin cofactor II deficiency]] | ||
*[[Heparin-induced thrombocytopenia]] | *[[Heparin-induced thrombocytopenia]] | ||
{{col-break|width=33%}} | |||
*[[Hormone replacement therapy]] | *[[Hormone replacement therapy]] | ||
*[[Hughes-Stovin syndrome]] | *[[Hughes-Stovin syndrome]] | ||
Line 174: | Line 177: | ||
*[[Hypertension]] | *[[Hypertension]] | ||
*[[Hyperviscosity]] | *[[Hyperviscosity]] | ||
*[[Immobilization]] | *[[immobility|Immobilization]] | ||
*[[Infection]] | *[[Infection]] | ||
*[[Inflammatory bowel disease]] | *[[Inflammatory bowel disease]] | ||
*[[Injury]] | *[[Injury]] | ||
*[[Interferon gamma]] | |||
*[[Intravenous drug use]] | *[[Intravenous drug use]] | ||
*[[Lenalidomide]] | *[[Lenalidomide]] | ||
Line 185: | Line 189: | ||
*[[May-Thurner syndrome]] | *[[May-Thurner syndrome]] | ||
*[[Meadows syndrome]] | *[[Meadows syndrome]] | ||
*[[Medroxyprogesterone]] | |||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Neuroleptic malignant syndrome]] | *[[Neuroleptic malignant syndrome]] | ||
Line 191: | Line 196: | ||
*[[Orthopedic surgery]] | *[[Orthopedic surgery]] | ||
*[[Ovarian hyperstimulation syndrome]] | *[[Ovarian hyperstimulation syndrome]] | ||
*[[Paget Schroetter disease]] | *[[Paget-Schroetter disease]] | ||
{{col-break|width=33%}} | |||
*[[Palbociclib]] | |||
*[[Pancreatic cancer]] | *[[Pancreatic cancer]] | ||
*[[Paroxysmal nocturnal hemoglobinuria]] | *[[Paroxysmal nocturnal hemoglobinuria]] | ||
*[[Pelvic vein thrombosis]] | *[[venous thrombosis|Pelvic vein thrombosis]] | ||
*[[Pergolide]] | |||
*[[plasminogen|Plasminogen deficiency]] | *[[plasminogen|Plasminogen deficiency]] | ||
*[[Polycystic ovary syndrome]] | *[[Polycystic ovary syndrome]] | ||
Line 217: | Line 225: | ||
*[[Tuberculosis]] | *[[Tuberculosis]] | ||
*[[Vascular surgery]] | *[[Vascular surgery]] | ||
*[[Vorinostat]] | |||
{{col-end}} | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Line 225: | Line 235: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Crowdiagnosis]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Latest revision as of 18:35, 7 June 2016
Resident Survival Guide |
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism causes On the Web |
Risk calculators and risk factors for Pulmonary embolism causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] The APEX Trial Investigators; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Pulmonary embolism (PE) is the acute obstruction of the pulmonary artery or one of its branches by a thrombus, air, tumor, or fat. Most often, PE is due to a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities, a process referred to as venous thromboembolism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Pulmonary embolism is a life-threatening condition and must be treated as such irrespective of the underlying cause.
Common Causes
- The most common cause of PE is a venous thrombus which has been dislodged from its site of formation in the deep veins of the lower extremities.
- Non-thrombotic causes of PE are: